Condition

Healthy Male

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 1 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials1

Recruiting0

Common interventions4

Lead sponsors shown1

Clinical trials

1 shown

Determining Highest Dose Administration of TC-5214 and Evaluating Effect on the Electrical Activity in the HeartNCT01359618 · 2011-06-01

TERMINATED

Common interventions

MoxifloxacinDRUG1 Moxifloxacin placebo comparatorOTHER1 Placebo comparatorOTHER1 TC-5214DRUG1

Mapped drugs appearing in these trials

Shared trial participation only; not evidence of efficacy or approval.

moxifloxacin1

Leading sponsors

AstraZeneca 1

Trial status mix

TERMINATED1

Phase mix

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.